In 2025, consolidated revenue rose to KRW 753.90 billion from KRW 715.38 billion in 2024, yet the company posted an operating loss of KRW 4.98 billion and an owner net loss of KRW 9.34 billion, extending losses for a second consecutive year.
Since 2024's operating loss of KRW 16.59 billion and owner net loss of KRW 22.14 billion were larger, 2025 can be characterized as a year of narrower losses alongside revenue growth.
In 2023 the company was profitable with operating income of KRW 22.18 billion and owner net income of KRW 5.04 billion, and 2022 was stronger still with operating income of KRW 30.90 billion and owner net income of KRW 17.44 billion, indicating a steady deterioration in profitability since 2022 that has shown signs of recovery starting in 2025.
On a quarterly basis, operating profit of KRW 4.26 billion in Q2 2025 gave way to an operating loss of KRW 1.13 billion in Q3, widening to a loss of KRW 5.78 billion in Q4, and Q1 2026 also posted an operating loss of KRW 3.53 billion, marking three consecutive quarters of losses.
However, Q2 2026 showed a clear swing to profit, with revenue of KRW 212.33 billion, operating profit of KRW 4.47 billion, and owner net income of KRW 3.57 billion.
Over the most recent four quarters (Q3 2025 through Q2 2026), cumulative owner net income remained negative at KRW -7.59 billion, so whether the single-quarter improvement translates into a sustained annual turnaround requires further confirmation in subsequent quarters.
On the balance sheet, the debt ratio rose from 77.7% in 2022 to 95.7% in 2023, 115.2% in 2024, and 112.1% in 2025, while operating cash flow, which had been solid at KRW 46.12 billion in 2022, KRW 72.57 billion in 2023, and KRW 21.04 billion in 2024, turned negative at KRW -33.13 billion in 2025, signaling a clear weakening in cash generation.
This can be attributed to a combination of investment burdens, including the KRW 43 billion Yulchon Chemical pangji business acquisition, and expanded working capital needs.